We are an established life-sciences venture capital firm with a long track record of consistent returns investing in best/first-in-class European Biopharma and HealthTech companies
Our seasoned team of domain experts possesses investment expertise, a deep scientific understanding of the life sciences field, and the passion to build companies. We work closely with ambitious entrepreneurs and invest progressively in the development of our portfolio companies. We thoughtfully build a diversified portfolio by indication, stage, technology and geography across Europe. We finance both early stage companies and corporate spin-offs with more mature assets, focusing on two life sciences themes:
HealthTech
Advances in digital technology are revolutionizing the healthcare…
Better diagnosis
Improved patient outcomes
Reduced costs
Investment stage: early commercialization and growth
Biopharma
First-in-class and best-in-class drugs are the backbone of innovation in healthcare
Novel targets
Focus on unmet needs
New chemical entities, biologics, advanced therapies
Investment stage: late pre-clinical / early clinical and growth
We completed our First Closing and continue to fund raise for Fund IV Final Close